The Hemp and Hemp-Derived CBD Consumer Protection and Market Protection Act would direct the Food and Drug Administration to outline a clear federal regulatory framework for hemp and hemp-derived products, promoting consumer safety.
The Supreme court ruled 8-0 that an Arkansas law prohibiting PBMs from reimbursing pharmacies at a lower rate than what the pharmacies pay to fill prescriptions is valid and not preempted by the federal Employee Retirement Income Security Act of 1974.
NACDS said it would be offering an interactive exhibit booth and one-on-one meetings for the duration of the National Association of Medicaid Directors’ 2020 Virtual Conference: Together Towards the Future.
SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for epilepsy, the agency said Monday.
The FDA announced the approval of Eisai's Fycompa (perampanel) tablets to treat partial-onset seizures in patients ages 12 years and older. Partial seizures are the most common type seen in people with epilepsy, according to the FDA.